Vetmedica, the animal health branch of Boehringer Ingelheim was founded in the 1950s, and established a UK presence in 1980. Since then, Vetmedica has expanded to one of the largest veterinary pharmaceutical companies in the UK, and is also one of the fastest growing.
Ranking among the top 10 animal companies in the world, innovation is and will always be at the heart of all Vetmedica’s activities. Through the discovery of new pharmaceutical solutions, molecules or vaccines we can offer added value to vets and animal owners.
Current estimates put the UK cat and dog population at around 14.5 million, making pets central to many people’s lives. In a trend that mirrors the demographic shift in the human population, our pets are living longer, healthier lives through improved nutrition and healthcare. This trend has created a real need for effective and safe treatments for chronic conditions such as osteoarthritis, heart disease, and cancer.
Our objective is to provide innovative animal health solutions for chronic care of dogs and cats, with the specific aim of improving the quality of life and longevity for these animals.
Seraquin’s TV Advert
You can write to us at: Boehringer Ingelheim, Ellesfield Avenue, Bracknell, Berks RG12 8YS.
You can also use the following Contact Form: